Grapefruit juice: Potential drug interaction;Il succo di pompelmo: Una potenziale interazione con i farmaci

Clinica Terapeutica

Volumn 156, Issue 3, 2005, Pages 97-103

  Palumbo, Giancarlo ^a   Bacchi, S ^a   Palumbo, P ^a   Primavera, L G ^a   Sponta, A M ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

CYP3A4; Grapefruit juice; P glicoprotein

Indexed keywords

AMIODARONE; AMLODIPINE; ATORVASTATIN; BENZODIAZEPINE; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CERIVASTATIN; CYCLOSPORIN; DIAZEPAM; DILTIAZEM; ETHINYLESTRADIOL; FELODIPINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; MIDAZOLAM; NIFEDIPINE; NIMODIPINE; PHENYTOIN; PRAVASTATIN; PREDNISONE; PROGESTERONE; QUINIDINE; SAQUINAVIR; SIMVASTATIN; TERFENADINE; TRIAZOLAM; TSUKUBAENOLIDE; UNINDEXED DRUG; VERAPAMIL; BENZODIAZEPINE DERIVATIVE; CYP3A PROTEIN, HUMAN; CYTOCHROME P450; GLYCOPROTEIN P;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; ENZYME INHIBITION; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; INTESTINE CELL; REVIEW; BEVERAGE; BIOAVAILABILITY; DRUG EFFECT; GRAPEFRUIT; HUMAN; INTESTINE ABSORPTION; METABOLISM;

BENZODIAZEPINES; BEVERAGES; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CITRUS PARADISI; CYCLOSPORINE; CYTOCHROME P-450 ENZYME SYSTEM; FOOD-DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTESTINAL ABSORPTION; P-GLYCOPROTEIN;

EID: 23844508521     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Gerda JJ, Normann SJ, Sullivan MP. Inhibition of atherosclerosis by dietary pectin in microswine with sustained hypercholesterolemia. Circulation 1994;89:1247-53
2. So FV, Guthrie N, Chambers AF, et al. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996;26:167-81
3. Bailey DG, Spence JD, Munoz C, et al. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9
4. Guthrie N, Carroll KK. Inhibition of mammary cancer by citrus flavonoid. Adv. Exp Med Biol 1998;439:227-36
5. Edgar B, Bailey D, Bergstrand R, et al. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine and its potential clinical relevance. Eur J Clin Pharmacol 1992;42:313-7
6. Kivisto KT, Lamberg TS, Kantola T, et al. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole. Clin Pharmacol Ther 1997;62:348-54
7. Floren LC, Bekersky I, Benet LZ, et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther 1997;62:41-9
8. Azie NE, Brater DC, Becker PA, et al. The interaction of diltiazem with lovastatin and pravastatin. Clin Pharmacol Ther 1998;64:369-77
9. Lundahl J, Regardh CG, Edgar B, et al. Effects of grapefruit juice ingestion - pharmacokinetic and haemodynamic of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharm 1997;52:139-45
10. Rashid TJ, Martin U, Clarke H, et al: Factors affecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol 1995;40:51-8
11. Kupferschmidt HH, Fattinger KE, Ha HR, et al.: Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 1998;45:355-9
12. Kupferschmidt HH, Ha HR, Ziegler WH, et al. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995;58:20-8
13. Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545-53
14. Schmiedlin-Ren, Edwards DJ, Fitzsimmons ME, et al. Mechanisms of enhanced oral availability of CYP3A4 by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 1997;25:1228-33
15. Lundahl J, Regardh CG, Edgar B, et al. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 1995;49:61-7
16. Maish WA, Hampton EM, Whitsett TL, et al. Influence of grapefruit juice on caffeine pharmacokinetics and pharmacodynamic. Pharmacotherapy 1996;16:1046-52
17. Fuhr U, Klittich K, Staib AH. Inhibitory effect of grapefruit juice and its bitter principal, naringerin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 1993;35:431-6
18. Fuhr U, Maier A, Keller A, et al. Lacking effect of grapefruit juice on the theophylline pharmacokinetic. Int J Clin Pharmacol Ther 1995;33:311-4
19. Lown KS, Kolars JC, Thummel KE, et al. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: lack of prediction by the erytromycin breath test. Drug Metab Dispos 1994;22:947-55
20. Soldner A, Christians U, Susanto M, et al. Grapefruit juice activates P-glycoprotein mediated drug transport. Pharm Res 1999;16:478-85
21. Kim RB, Fromm MF, Wandel C et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1998;101:289-94
22. Lown KS, Mayo RR, Leichtman AB, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997;62:248-60
23. Yee GC, Stanley DL, Pessa LJ et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;345:955-6
24. Proppe DG, Hoch OD, McLean AJ, et al. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. Br J Clin Pharmacol 1995;39:337-8 (letter)
25. Taniguchi S, Kobayashi H, Ishii M. Treatment of psoriasis by cyclosporine and grapefruit juice. Arch Dermatol 1996;132:1249 (letter)
26. Emilia G, Longo G, Bertesi M, et al. Clinical interaction between grapefruit juice and cyclosporine: is there any interest for the hematologists? Blood 1998;91:362-3 (letter)
27. Brunner LJ, Munar MY, Vallian J, et al. Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients. Pharmacother 1998;18:23-9
28. Majeed A, Kareem A. Effect of grapefruit juice on cyclosporine pharmacokinetics. Pediatr Nephrol 1996;10:395-6 (letter)
29. Johnston A, Holt DW. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;346:122-3 (letter)
30. Bailey DG, Arnold JM, Munoz C, et al. Grapefruit juice felodipine interaction: mechanism, predictability, and effect of naringin. Clin pharmacol Ther 1993;53:637-42
31. Hoing PK, Wortham DC, Lazarev A, et al. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996;36:345-51
32. Rogers JD, Zhao J, Liu LD, et al. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzime A reductase inhibitors. Clin pharmacol Ther 1999;66:358-66
33. Veronese M, Burke J, Dorval E, et al. Grapefruit juice (GFJ) inhibits hepatic and intestinal CYP3A4 dose-dependentiy Clin Pharmacol Ther 2000;67:151 Abstract PIII-37
34. Ubeaud G, Hagenbach J, Vandenschrieck S, et al. In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin. Life Sci 1999;65:1403-12
35. Miniscalco A, Lundahl J., Regardh CG, et al. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992;261:1195-9
36. Fukuda K, Ohta T, Oshima Y, et al. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimmers as components of drug interaction. Pharmacogen 1997;7:391-6
37. Fuhr U, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin pharmacol Ther 1995;58:365-73
38. Bailey DG, Kreeft JH, Munoz C, et al. Grapefruit juice-felodipine interaction: effect of naringin and 6′, 7′-dihydroxy-bergamottin in humans. Clin Pharmacol Ther 1998;64:248-56
39. Edwards DJ, Bellevue FH, Woster PM. Identification of 6′,7′-dihydroxybergamottin, a cytocrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996;24:1287-90
40. He K, Iyer KR, Hayes RN, et al. Inactivation of cytocrome P450 3A4 by bergamottin, a component of a grapefruit juice. Chem Res Toxicol 1998;11:252-9
41. Bailey DG, Arnold JM, Bend JR, et al. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. Br J Clin Pharmacol 1995;40:135-40
42. Zaidenstein R, Dishi V, Gips M, et al. The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil. Eur J Clin Pharmacol 1998;54:337-40
43. Ioannides-Demos LL, Christophidis N, Ryan P, et al. Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentration in patients with autoimmune diseases. J Rheumatol 1997;54:24-9
44. Ku YM, Min DI, Flanigan M. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter? J Clin Pharmacol 1998;38:959-65
45. Keogh A, Spratt P, McCosker C, et al. Ketokonazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 1995;333:628-33
46. Kantola T, Kivisto KT, Neuvonen PJ. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998;63:337-402
47. Corpier CL, Jones PH, Suki WN, et al. Rhabdomyolysis and renal injury with lovastatin use: report of two cases in cardiac transplant recipients. JAMA 1998;260:239-41
48. Ahmad S: Diltiazem myopathy. Am Heart J 1993;126:1494-5 (letter)
49. Spach DH, Bauwens JE, Clark CD, et al. Rhabdomyolysis associated with lovastatin and erythromycin use. West J Med 1991;154:213-5
50. Ozdemir M, Aktan Y; Boydag BS, et al. Interaction between grapefruit juice and diazepam in humans. Eur J Drug Metab Pharmacokinet 1998;23:55-9
51. Weber A, Jager R, Borner A, et al. Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 1996;53:41-7
52. Lee YS, Lorenzo BJ, Koufis T, et al. Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase. Clin Pharmacol Ther 1996;59:62-71